Baptist University’s CDD-2101 first botanical drug authorised for clinical trials in United States, which could lead to international market.
University scientists in Hong Kong get rare US approval for clinical trials of new Chinese medicine-based constipation treatment
RELATED ARTICLES
Arab World Sees Crackdown on RT as Admission of Role Russian Media Plays ‘Conveying Truth to People’
Wikipedia bans user for ‘alleged trolling, doxxing and intimidation’ of Hong Kong journalists
Russia mulls titanium and uranium export caps – deputy FM